11-56275921-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004745.2(OR5T1):c.283G>A(p.Val95Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000545 in 1,614,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004745.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5T1 | NM_001004745.2 | c.283G>A | p.Val95Ile | missense_variant | 3/3 | ENST00000641665.1 | NP_001004745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5T1 | ENST00000641665.1 | c.283G>A | p.Val95Ile | missense_variant | 3/3 | NM_001004745.2 | ENSP00000493364 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000876 AC: 22AN: 251274Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135804
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461854Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727230
GnomAD4 genome AF: 0.000335 AC: 51AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.283G>A (p.V95I) alteration is located in exon 1 (coding exon 1) of the OR5T1 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the valine (V) at amino acid position 95 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at